首页> Clinical orthopaedics and related research> Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal Metastases from Lung Cancer? A Systematic Review and Network Meta-analysis.

Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal Metastases from Lung Cancer? A Systematic Review and Network Meta-analysis.

导出 OA

翻译打印收藏纠错

第一作者： Anthony,Bozzo

第一单位： Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.

作者： Anthony,Bozzo ^[1] ; Jiawen,Deng ^[2] ; Umaima,Abbas ^[2] ; Richa,Bhasin ^[2] ; Marisa,Deodat ^[2] ; Sajid,Wariach ^[2] ; Stephanie,Sanger ^[2] ; Daniel,Axelrod ^[1] ; Karim,Masrouha ^[3] ; Robert,Turcotte ^[4] ; David,Wilson ^[3] ; Michelle,Ghert ^[5]

作者单位： Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada. ^[1] Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada. ^[2] Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.;Hamilton Health Sciences, Juravinski Hospital and Cancer Center, Hamilton, Ontario, Canada. ^[3] Division of Orthopaedic Surgery, McGill University, Montreal, Quebec, Canada. ^[4] Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.;Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.;Hamilton Health Sciences, Juravinski Hospital and Cancer Center, Hamilton, Ontario, Canada. ^[5]